HOME >> BIOLOGY >> NEWS
Key gene in orchestrating embryo development also fine tunes organization of the retina

the horizontal cells to stop multiplying so there will be only a limited number of these neurons," Dyer said. "So this study also helps to explain the big mystery of how horizontal cells succeed in making that critical ratio."

This latest discovery adds to the growing list of roles Prox1 plays. "Prox1 has been a central gene in every organ we've studied so far in the developing embryo," Oliver said. "We've previously discovered that Prox1 is critical to the normal development of the liver, the lens of the eye, and the entire lymphatic system, which is a critical part of the immune system."

The ongoing work at St. Jude has demonstrated that during embryo development, Prox1 plays at least three critical roles. It controls the proliferation of cells, prompts cells to migrate from their original positions in the embryo to the location where they will help form a tissue or organ and makes those cells become a very specialized cell type so they perform a specific task in that organ or tissue. Other authors of this report include Constance L. Cepko (Harvard University, Boston) and Frederick J. Livesey (Harvard University and Wellcome/CRC Institute of Cancer and Developmental Biology, University of Cambridge, UK).


'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
1-May-2003


Page: 1 2

Related biology news :

1. Sequential signals choreograph embryonic tubule formation
2. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
3. Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics
4. MIT technology jump-starts human embryonic stem cell work
5. Genetic testing of embryos to pick savior sibling OK with most Americans
6. Researchers model embryo implantation and tumour metastasis in fruit flies
7. New human embryonic stem-cell lines to be made available to researchers
8. Most clones doomed from the start, according to Temple University embryologist
9. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
10. Human embryonic stem cells may promise medical advances
11. Destructive wizardry of Ozz-E3 ligase appears key to building skeletal muscles in embryos and adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
(Date:2/16/2017)... , ... February 16, 2017 , ... ... case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on ... performed on a 55-year-old practicing female physician suffering from degenerative disc disease with ...
Breaking Biology Technology:
Cached News: